IRIS Accounts Production v23.2.0.158 06449860 director 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064498602022-03-31064498602023-03-31064498602022-04-012023-03-31064498602021-03-31064498602021-04-012022-03-31064498602022-03-3106449860ns10:Originalns15:EnglandWales2022-04-012023-03-3106449860ns14:PoundSterlingns10:Original2022-04-012023-03-3106449860ns10:Originalns10:Director12022-04-012023-03-3106449860ns10:Original2022-04-012023-03-3106449860ns10:Original2023-03-3106449860ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3106449860ns10:Originalns10:SmallEntities2022-04-012023-03-3106449860ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3106449860ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3106449860ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3106449860ns10:Originalns10:FullAccounts2022-04-012023-03-3106449860ns10:Original12022-04-012023-03-3106449860ns10:CompanySecretary1ns10:Original2022-04-012023-03-3106449860ns10:Originalns10:RegisteredOffice2022-04-012023-03-3106449860ns10:Original2022-03-3106449860ns10:Originalns5:CurrentFinancialInstruments2023-03-3106449860ns10:Originalns5:CurrentFinancialInstruments2022-03-3106449860ns10:Originalns5:Non-currentFinancialInstruments2023-03-3106449860ns10:Originalns5:Non-currentFinancialInstruments2022-03-3106449860ns5:ShareCapitalns10:Original2023-03-3106449860ns5:ShareCapitalns10:Original2022-03-3106449860ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3106449860ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3106449860ns10:Originalns5:NetGoodwill2022-04-012023-03-3106449860ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3106449860ns10:Originalns5:FurnitureFittings2022-04-012023-03-3106449860ns10:Originalns5:MotorVehicles2022-04-012023-03-3106449860ns10:Originalns5:ComputerEquipment2022-04-012023-03-3106449860ns10:Original2021-04-012022-03-3106449860ns10:Originalns5:NetGoodwill2022-03-3106449860ns10:Originalns5:NetGoodwill2023-03-3106449860ns10:Originalns5:NetGoodwill2022-03-3106449860ns10:Originalns5:LandBuildings2022-03-3106449860ns10:Originalns5:ShortLeaseholdAssetsns5:LandBuildings2022-03-3106449860ns10:Originalns5:FurnitureFittings2022-03-3106449860ns10:Originalns5:LandBuildings2022-04-012023-03-3106449860ns10:Originalns5:ShortLeaseholdAssetsns5:LandBuildings2022-04-012023-03-3106449860ns10:Originalns5:LandBuildings2023-03-3106449860ns10:Originalns5:ShortLeaseholdAssetsns5:LandBuildings2023-03-3106449860ns10:Originalns5:FurnitureFittings2023-03-3106449860ns10:Originalns5:LandBuildings2022-03-3106449860ns10:Originalns5:ShortLeaseholdAssetsns5:LandBuildings2022-03-3106449860ns10:Originalns5:FurnitureFittings2022-03-3106449860ns10:Originalns5:MotorVehicles2022-03-3106449860ns10:Originalns5:ComputerEquipment2022-03-3106449860ns10:Original2022-03-3106449860ns10:Originalns5:MotorVehicles2023-03-3106449860ns10:Originalns5:ComputerEquipment2023-03-3106449860ns10:Originalns5:MotorVehicles2022-03-3106449860ns10:Originalns5:ComputerEquipment2022-03-3106449860ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106449860ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31
REGISTERED NUMBER: 06449860 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

Tans Pharm Ltd

Tans Pharm Ltd (Registered number: 06449860)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Tans Pharm Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTOR: Mrs M Pun





SECRETARY: Mr S Pun





REGISTERED OFFICE: High Street
Timsbury
Bath
BA2 0HT





REGISTERED NUMBER: 06449860 (England and Wales)





ACCOUNTANTS: Accounting Solutions
2 Northside
Wells Road
Chilcompton
Radstock
BA3 4ET

Tans Pharm Ltd (Registered number: 06449860)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 133,950 156,275
Tangible assets 5 447,223 437,811
581,173 594,086

CURRENT ASSETS
Stocks 47,872 33,903
Debtors 6 370,226 160,717
Cash at bank and in hand 87,987 359,937
506,085 554,557
CREDITORS
Amounts falling due within one year 7 234,763 494,378
NET CURRENT ASSETS 271,322 60,179
TOTAL ASSETS LESS CURRENT
LIABILITIES

852,495

654,265

CREDITORS
Amounts falling due after more than one
year

8

180,791

-
NET ASSETS 671,704 654,265

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 671,604 654,165
SHAREHOLDERS' FUNDS 671,704 654,265

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Tans Pharm Ltd (Registered number: 06449860)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 November 2023 and were signed by:





Mrs M Pun - Director


Tans Pharm Ltd (Registered number: 06449860)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Tans Pharm Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2009, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tans Pharm Ltd (Registered number: 06449860)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2022 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 446,500
AMORTISATION
At 1 April 2022 290,225
Amortisation for year 22,325
At 31 March 2023 312,550
NET BOOK VALUE
At 31 March 2023 133,950
At 31 March 2022 156,275

5. TANGIBLE FIXED ASSETS
Fixtures
Freehold Short and
property leasehold fittings
£    £    £   
COST
At 1 April 2022 413,753 4,143 61,998
Additions - - 16,168
At 31 March 2023 413,753 4,143 78,166
DEPRECIATION
At 1 April 2022 - - 53,994
Charge for year - - 4,834
At 31 March 2023 - - 58,828
NET BOOK VALUE
At 31 March 2023 413,753 4,143 19,338
At 31 March 2022 413,753 4,143 8,004

Tans Pharm Ltd (Registered number: 06449860)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

5. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2022 35,459 6,607 521,960
Additions - 2,068 18,236
At 31 March 2023 35,459 8,675 540,196
DEPRECIATION
At 1 April 2022 24,913 5,242 84,149
Charge for year 2,637 1,353 8,824
At 31 March 2023 27,550 6,595 92,973
NET BOOK VALUE
At 31 March 2023 7,909 2,080 447,223
At 31 March 2022 10,546 1,365 437,811

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors - 8,513
Other debtors 370,226 152,204
370,226 160,717

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 30,173 239,076
Trade creditors 159,168 113,933
Taxation and social security 18,903 32,209
Other creditors 26,519 109,160
234,763 494,378

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 180,791 -